Chaitanya Asawa
Chaitanya Asawa is an engineering leader at Abridge, where he works on AI-powered clinical decision support and clinician-directed workflows. He has written publicly about Abridge’s model strategy, evaluation, and contextual decision support, and previously worked in AI and robotics research at Vicarious AI and in engineering at Glean.
Abridge Says GPT-5.5 Improves Clinical Synthesis as Tool Complexity Rises
Abridge’s Chaitanya Asawa says GPT-5.5 improved the company’s clinical decision-support system as it added more tools and context, a signal that the model could better synthesize information under complexity. His case is that stronger reasoning and tool use can turn patient context, live clinical conversation, and trusted medical guidance into denser point-of-care support, while leaving clinicians to review answers and accept or reject proposed note edits.
Abridge Bets Clinical Conversations Can Become Healthcare’s Intelligence Layer
Abridge executives Janie Lee and Chaitanya “Chai” Asawa argue that the patient-clinician conversation is becoming healthcare’s core intelligence layer, not merely an input for automated notes. In a discussion with Redpoint’s Jacob Effron, they describe Abridge’s move from ambient documentation into clinical decision support, prior authorization and other workflows that depend on EHR data, payer rules, medical literature and local guidelines. Their case is that healthcare AI will be judged less by chatbot fluency than by whether it can deliver accurate, low-latency, privacy-preserving support inside clinical workflows without adding to clinicians’ alert burden.